) Among several hundred known cancer-associated genes, a substantial number remain to be clearly assigned to biochemical pathways. In addition, as more efficient genomic methods are developed, the number of potential cancer genes is increasing rapidly. It is therefore important to develop and exploit high-throughput methods to reveal functional interactions among components of signaling pathways. We describe our proposed contribution to assign key breast gene products to particular signaling pathways and determine the steps at which they function. The strategy is based on the identification and validation, using the two-hybrid system, of potential physical interactions mediated by gene products related to normal breast development and/or breast tumor formation. We have recently developed a version of the two-hybrid system that solves most of the common problems of the methods, including the relatively high number of false positives In addition, since the current versions of the two-hybrid system also fail to provide a clear link between potential physical interaction in yeast and functional interaction in vivo, we have developed a """"""""reverse two-hybrid"""""""" system that efficiently generates alleles that are defective for protein:protein interaction or trans-acting dissociating molecules. Such reagents can be used to assess the functional significance of potential interactions in the relevant in vivo biological system. This section of the Program Project Grant describes a Functional Genomics Core referred to as """"""""Protein Interaction Core"""""""" or """"""""Scientific Core B"""""""". The Protein Interaction Core is composed in turn of two components: 1) A """"""""Service Component"""""""" aimed at performing forward and reverse two-hybrid screens for the other projects described in the Program, and 2) A """"""""Technology Development Component"""""""" aimed at developing functional genomic strategies to identify interacting proteins for the currently known key breast gene products. We plan to develop a semi-automated version of the two-hybrid system to identify protein:protein interactions in large-scale screens. In addition, we plan to develop semi-automated version of the reverse two-hybrid system which should provide functional information about the protein:protein interactions identified. The resulting information will be released in the form of a publicly available database, providing a tool for the community of breast cancer researchers, including our colleagues on this grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080111-04
Application #
6563947
Study Section
Subcommittee G - Education (NCI)
Project Start
2002-02-01
Project End
2003-01-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
$291,807
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
076580745
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Xiao, Tengfei; Li, Wei; Wang, Xiaoqing et al. (2018) Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A 115:7869-7878
Zhang, Jinfang; Bu, Xia; Wang, Haizhen et al. (2018) Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature 553:91-95
Li, Andrew G; Murphy, Elizabeth C; Culhane, Aedin C et al. (2018) BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1? activation. Proc Natl Acad Sci U S A 115:E9600-E9609
Wu, Yanming; Zhang, Zhao; Cenciarini, Mauro E et al. (2018) Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ER?-GREB1 Transcriptional Axis. Cancer Res 78:671-684
Witwicki, Robert M; Ekram, Muhammad B; Qiu, Xintao et al. (2018) TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer. Cell Rep 25:1255-1267.e5
Jeselsohn, Rinath; Bergholz, Johann S; Pun, Matthew et al. (2018) Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell 33:173-186.e5
Hinohara, Kunihiko; Wu, Hua-Jun; Vigneau, Sébastien et al. (2018) KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell 34:939-953.e9
Wan, Lixin; Xu, Kexin; Wei, Yongkun et al. (2018) Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Mol Cell 69:279-291.e5
Bierie, Brian; Pierce, Sarah E; Kroeger, Cornelia et al. (2017) Integrin-?4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A 114:E2337-E2346
Hydbring, Per; Wang, Yinan; Bogorad, Roman L et al. (2017) Identification of cell cycle-targeting microRNAs through genome-wide screens. Cell Cycle 16:2241-2248

Showing the most recent 10 out of 136 publications